TICKERNERD
Menu
ALHCALHCHealthcare · Healthcare Plans

ALHC Stock Forecast: Alignment Healthcare, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026
$8.35
−4.02% on the day

The 14 Wall Street analysts covering Alignment Healthcare, Inc. hold a median 12-month price target of $22 — +163.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 19 Sept 2026 — in the upper half.

Market cap
$1.7B
Ticker Nerd rank
62 / 100
Median analyst target
$22
Analysts covering
14
Revenue$1.3B+31.6% y/y
Operating income$42.1M
Net income$36.6M
Free cash flow−$27.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−33.8%
1M
−36.9%
YTD
−57.7%
1Y
−49.3%
From 52W high
−66.0%
From 52W low
0.0%
$8
$25
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ALHC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Alignment Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
62 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
81
Accruals
74
Value
66
Volatility
66
Quality
60
Revisions
60
Issuance
41
Size
38
Momentum
24

Growth (81): Sales and profits are climbing, and climbing faster than before.

Momentum (24): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ALHC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALHC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20$25$30Oct 25Jan 26Apr 26Jul 26ALHCHigh $28Median $22Low $13

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says14 analysts
12 Buy2 Hold0 Sell
Low $13Median $22High $28

The green dot is the last close — the median target sits +163.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 0 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
4 Aug 2026JP MorganMaintainsOverweight$26 → $22
3 Aug 2026Raymond JamesDowngradeOutperform$22 → $19
26 May 2026BarclaysMaintainsEqual-Weight$19 → $16
26 May 2026BarclaysMaintainsEqual-Weight—
1 May 2026BarclaysMaintainsEqual-Weight—
1 May 2026UBSMaintainsNeutral—
5 Feb 2026JP MorganMaintainsOverweight—
16 Jan 2026TD CowenMaintainsBuy—
14 Jan 2026UBSMaintainsNeutral—
6 Jan 2026Piper SandlerMaintainsOverweight—
17 Dec 2025JP MorganMaintainsOverweight—
24 Nov 2025JP MorganUpgradeOverweight—
5 Nov 2025JP MorganMaintainsNeutral—
3 Nov 2025BarclaysMaintainsEqual-Weight—
31 Oct 2025UBSMaintainsNeutral—
14 Oct 2025Goldman SachsInitiatesBuy—
25 Aug 2025KeybancUpgradeOverweight—
31 July 2025BarclaysUpgradeEqual-Weight—
2 May 2025UBSMaintainsNeutral—
15 Apr 2025BairdMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALHC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ALHC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, Alignment Healthcare, Inc. returned −49.3% against +16.3% for the S&P 500, dividends included.

ALHC vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140160Oct 25Jan 26Apr 26Jul 26ALHCS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ALHC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.8%
Analysts raising
3
Analysts cutting
0
Fundamentals

Alignment Healthcare, Inc. (ALHC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
43.9×

Cheaper than 16% of US stocks

Price / sales
0.4×

Cheaper than 86% of US stocks

Price / book
6.5×

Cheaper than 15% of US stocks

EV / EBITDA
15.6×

Cheaper than 21% of US stocks

Growth & margins
Revenue growth (YoY)
31.6%

Higher than 79% of US stocks

Earnings growth (YoY)
133.4%

Higher than 87% of US stocks

Gross margin
13.5%

Higher than 13% of US stocks

Operating margin
3.2%

Higher than 51% of US stocks

Net margin
0.9%

Higher than 49% of US stocks

Returns & dividend
Return on equity
20.0%

Higher than 81% of US stocks

Return on assets
3.1%

Higher than 65% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Alignment Healthcare, Inc. (ALHC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Alignment Healthcare, Inc. has a market value of $1.7B and an enterprise value of $1.4B.

  • Revenue in the twelve months to 30 June 2026: $4.6B. The latest quarter grew 31.6% year on year.

  • Net income over the same four quarters: $40.7M, a 0.9% net margin.

  • Diluted earnings per share, trailing twelve months: $0.19.

  • Free cash flow in the twelve months to 30 June 2026: $177.5M.

  • Shares outstanding: 207.2M.

  • Trailing P/E: 43.9×; forward P/E: 11.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Alignment Healthcare, Inc. employs 1,849 people — $2.5M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Sept 2026

Data provided by Twelve Data

Peers

ALHC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
ALHCAlignment Healthcare, Inc.$1.7B
62
PGNYProgyny, Inc.$2.1B
96
CLOVClover Health Investments Corp.$2.3B
67
OSCROscar Health, Inc.$9.6B
87
MOHMolina Healthcare, Inc.$10.3B
35
CNCCentene Corp.$32.0B
95
ANIPANI Pharmaceuticals, Inc.*$1.7B
93

* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Alignment Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ALHC news & analysis

Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

GlobeNewsWire · 17 Sept 2026negative

Law Offices of Howard G. Smith announced a securities fraud investigation into Alignment Healthcare, Inc. (ALHC) and is contacting shareholders who lost money. The firm issued the notice from Bensalem, Pa. on Sept. 17, 2026 via GlobeNewsWire.

Why it matters — An active securities fraud investigation and outreach to affected shareholders signals potential legal and reputational concerns for ALHC that watchers may want to monitor.

ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures

GlobeNewsWire · 16 Sept 2026negative

Hagens Berman announced it is updating its investigation into Alignment Healthcare following a nearly 20% stock decline on Tuesday after management made disclosures at an analyst conference. The law firm says the probe is being conducted on behalf of investors.

Why it matters — An ongoing investor investigation and sharp share-price drop could signal concerns around the company's disclosures that ALHC watchers may want to monitor.

Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

GlobeNewsWire · 16 Sept 2026negative

The Law Offices of Frank R. Cruz announced it is continuing an investigation into Alignment Healthcare, Inc. regarding possible violations of federal securities laws, and is urging shareholders who have lost money to contact the firm.

Why it matters — The ongoing securities fraud investigation signals potential legal and regulatory risk for ALHC shareholders.

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors With Losses to Learn More About the Investigation

GlobeNewsWire · 14 Sept 2026negative

Kaplan Fox & Kilsheimer LLP announced it is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC). The law firm is encouraging investors who have suffered losses to learn more about the investigation.

Why it matters — An active securities investigation by a law firm could raise concerns among ALHC investors about potential legal or regulatory issues facing the company.

Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen

GlobeNewsWire · 10 Sept 2026negative

Alignment Health released its fifth annual survey, finding that seniors are falling further behind as key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt. The report highlights that these challenges continue to rise as support gaps widen.

Why it matters — This survey signals growing challenges and unmet needs among seniors, a core demographic for Alignment Healthcare, which could affect demand for its senior-focused services and plans.

FAQ

Frequently asked questions about ALHC stock

What is the ALHC stock price forecast for 2026-2027?

The 14 Wall Street analysts covering Alignment Healthcare, Inc. have a median 12-month price target of $22, with estimates ranging from $13 to $28. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ALHC stock a buy right now?

Of the 14 analysts covering Alignment Healthcare, Inc., 12 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Alignment Healthcare, Inc. 62 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ALHC?

As at 19 Sept 2026, Alignment Healthcare, Inc. ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (81 of 100).

Will ALHC stock go up?

No one can know that. What the data says: the median 12-month target from 14 analysts implies +163.5% from the last close, and Ticker Nerd's factor model ranks Alignment Healthcare, Inc. 62 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ALHC stock forecast for 2030?

No analyst covering Alignment Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALHC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $28 over the next 12 months.

How has ALHC stock performed over the past year?

Alignment Healthcare, Inc. returned -49.3% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Alignment Healthcare, Inc. do?

Alignment Healthcare, Inc. is a managed healthcare company focused on Medicare Advantage plans for seniors in the United States.

What is the latest news on ALHC?

The most recent item we track (GlobeNewsWire, 17 Sept 2026): "Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation". Law Offices of Howard G. Smith announced a securities fraud investigation into Alignment Healthcare, Inc. (ALHC) and is contacting shareholders who lost money. The firm issued the notice from Bensalem, Pa. on Sept. 17, 2026 via GlobeNewsWire.

Company

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc. is a managed healthcare company focused on Medicare Advantage plans for seniors in the United States. The company provides a consumer-centric healthcare platform designed to coordinate coverage and care through customized health plan offerings, local provider partnerships, and technology-enabled support. Its services are built to help members navigate benefits, access care, and manage their health through tools such as member portals, mobile apps, concierge-style assistance, and care coordination resources. Alignment Healthcare serves seniors and Medicare beneficiaries in selected U.S. markets, with a business model centered on improving the experience of health plan members while working closely with providers and care teams. Headquartered in Orange, California, Alignment Healthcare plays a specialized role in the managed care sector by combining insurance coverage with clinical and digital support services.

CEO Mr. John E. Kao · 1,849 employees · United States · https://www.alignmenthealth.com